DNA-testing company 23andMe made headlines last week when it announced that it would share consumers' anonymized genetic data (https://www.businessinsider.com/dna-testing-delete-your-data-23andme-ancestry-2018-7) with pharmaceutical giant GlaxoSmithKline as part of a $300-million deal.
https://www.businessinsider.com/dna-testing-ancestry-23andme-share-data-companies-2018-8?amp
